- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: JNJ 28431754
I alt 880 resultater
-
Janssen Pharmaceutica N.V., BelgiumAfsluttetSkizofreni | Kognitionsforstyrrelser | Alzheimers sygdomTyskland
-
Janssen Pharmaceutical K.K.Afsluttet
-
University of TurkuOulu University Hospital; Tampere University Hospital; Satakunta Central...AfsluttetBlødning | Embolisme | TromboseFinland
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumAfsluttetNeoplasmer | LymfomDet Forenede Kongerige
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetMyelodysplastiske syndromer | Advanced or Refractory LeukemiaForenede Stater
-
Janssen Research & Development, LLCAfsluttet
-
Yale UniversityPfizer; Avid RadiopharmaceuticalsAfsluttetDiabetes mellitus, type 1Forenede Stater
-
Johnson & Johnson Pharmaceutical Research & Development...Trukket tilbage
-
Janssen Research & Development, LLCThe Scripps Research InstituteTrukket tilbage
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Furiex Pharmaceuticals, IncAfsluttetKomplicerede hud- og hudstrukturinfektionerForenede Stater
-
Furiex Pharmaceuticals, IncAfsluttetCommunity-erhvervet bakteriel lungebetændelse (CABP)Forenede Stater, Canada, Colombia, Tyskland, Ungarn, Polen
-
Texas Tech UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.AfsluttetArsenisk melanose | Arsenisk Keratose | Arseniske kræftformer | Arsenikose | Arseneksponering | Arsen toksicitet | ArsenforgiftningBangladesh
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaAfsluttetBrystneoplasmer | LymfødemCanada
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetSund og rask | Farmakokinetik | Lægemiddelinteraktioner
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetSund og rask | Farmakokinetik
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumAfsluttetFarmakokinetik | Avancerede maligniteter | Solide Maligniteter | Proteinkinasehæmmere | Maksimal tolereret dosis | Antineoplastiske protokoller | Klinisk forsøg, fase 1
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders med hyperaktivitet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders med hyperaktivitet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
SanofiAfsluttetStørre depressiv lidelseForenede Stater, Canada
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Afsluttet
-
AttenuonProstate Cancer Clinical Trials ConsortiumUkendt
-
AttenuonUkendt
-
National Center for Research Resources (NCRR)Stanford UniversityUkendtTvangslidelseForenede Stater